AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Dare Bioscience, Inc. Director's Dealing 2014

Apr 10, 2014

34825_dirs_2014-04-10_e8a15a4f-67c5-44d8-912a-1fa171e0c885.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-04-10

Reporting Person: Sasisekharan Ram (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	82715	Direct

Footnotes

F1: Reflects a 1-for-14.5074 reverse stock split effected on March 31, 2014.